Evidence map›Paper›PMID 35242250›Full record

ArticleCanadian respiratory journal2022

Sustained Impairment in Cardiopulmonary Exercise Capacity Testing in Patients after COVID-19: A Single Center Experience.

Georg Evers, Arik Bernard Schulze, Irina Osiaevi, Kimon Harmening, Richard Vollenberg, Rainer Wiewrodt, Rudin Pistulli, Matthias Boentert, Phil-Robin Tepasse, Juergen R Sindermann and 2 more

Abstract read
In one paragraph

Article in Canadian respiratory journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. IL-24 in COVID-19 Patients: Correlations with Disease Progression.International journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Georg EversDepartment of Medicine A,Hematology,Oncology and Pulmonary Medicine, University Hospital Münster, Münster, Germany.ORCID 0000-0003-3773-1416
Arik Bernard SchulzeDepartment of Medicine A,Hematology,Oncology and Pulmonary Medicine, University Hospital Münster, Münster, Germany.ORCID 0000-0002-1644-3573
Irina OsiaeviDepartment of Medicine A,Hematology,Oncology and Pulmonary Medicine, University Hospital Münster, Münster, Germany.ORCID 0000-0002-6068-9327
Kimon HarmeningDepartment of Medicine A,Hematology,Oncology and Pulmonary Medicine, University Hospital Münster, Münster, Germany.ORCID 0000-0001-7194-172X
Richard VollenbergDepartment of Medicine B for Gastroenterology,Hepatology,Endocrinology and Clinical Infectiology, University Hospital Münster, Münster, Germany.ORCID 0000-0003-3208-7924
Rainer WiewrodtDepartment of Medicine A,Hematology,Oncology and Pulmonary Medicine, University Hospital Münster, Münster, Germany.ORCID 0000-0002-8690-7417
Rudin PistulliDepartment of Cardiology I,Coronary and Peripheral Vascular Disease and Heart Failure, University Hospital Münster, Münster, Germany.ORCID 0000-0001-7676-3942
Matthias BoentertDepartment of Neurology, University Hospital Münster, Münster, Germany.ORCID 0000-0001-6133-1397
Phil-Robin TepasseDepartment of Medicine B for Gastroenterology,Hepatology,Endocrinology and Clinical Infectiology, University Hospital Münster, Münster, Germany.ORCID 0000-0002-2757-4755
Juergen R SindermannDepartment of Cardiology I,Coronary and Peripheral Vascular Disease and Heart Failure, University Hospital Münster, Münster, Germany.ORCID 0000-0002-1370-0060
Ali YilmazDepartment of Cardiology I,Coronary and Peripheral Vascular Disease and Heart Failure, University Hospital Münster, Münster, Germany.ORCID 0000-0003-4526-8679
Michael MohrDepartment of Medicine A,Hematology,Oncology and Pulmonary Medicine, University Hospital Münster, Münster, Germany.ORCID 0000-0003-0317-4367

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Following COVID-19, patients often present with ongoing symptoms comparable to chronic fatigue and subjective deterioration of exercise capacity (EC), which has been recently described as postacute COVID-19 syndrome. Objective: To objectify the reduced EC after COVID-19 and to evaluate for pathologic limitations. Methods: Thirty patients with subjective limitation of EC performed cardiopulmonary exercise testing (CPET). If objectively limited in EC or deteriorated in oxygen pulse, we offered cardiac stress magnetic resonance imaging (MRI) and a follow-up CPET. Results: Eighteen male and 12 female patients were included. Limited relative EC was detected in 11/30 (36.7%) patients. Limitation correlated with reduced body weight-indexed peak oxygen (O Conclusions: Deterioration of EC was not associated with ventilatory or pulmonary vascular limitation. Exercise limitation was related to both reduced O

Indexed as

COVID-19Exercise TestExercise ToleranceFemaleHumansLungMaleOxygen ConsumptionSARS-CoV-2

Identifiers

PMID35242250
PMCPMC8886771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.